The program of the International Agency for Research on Cancer (IARC) Monographs on the Evaluation of Carcinogenic Risks to Humans convened a Working Group of experts and observers from 11 countries in Lyon, France, 4 to 11 February 1997 to evaluate the evidence that polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs) might be risk factors for human cancer (1) . Although quantitative information, including doseresponse relationships, was important in reaching the conclusions of the meeting, the question of quantitative risk estimation was not addressed by the Working Group. This meeting marked the third time PCDDs were considered within this program. In 1977 few data were available and no evaluation of PCDDs could be made, either on the basis of animal carcinogenicity evidence or reports of people exposed to contaminated herbicides (2) . By 1987 the animal carcinogenicity data had developed to the stage where there was sufficient evidence for the carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD or dioxin, the PCDD that has caused most concern), but the epidemiologic evidence remained inadequate (3) . Accordingly (4) (5) (6) . PCDFs and PCDDs also may be produced in thermal processes such as incineration and metal processing and in the bleaching of paper pulp with free chlorine (7) (8) (9) . PCDFs also are found in residual waste from the production of vinyl chloride and the chloralkali process for chlorine production (10) (11) (12) (13) (14) . The (15) and from the consumption of contaminated rice oils. The latter have caused specific illnesses to which the locally descriptive names for oil disease have been given: Yusho in Japan (16) and Yu-cheng in Taiwan (17) .
In human tissues, current mean background levels of TCDD are in the range of 2 to 3 ng/kg fat; the sum of the penta-and (18) and the Netherlands (19) , two in Germany (20, 21) ]. These studies involve the highest exposures to TCDD among all epidemiologic studies. The cohort of residents in a contaminated area from Seveso, Italy, is well known, but the exposures at Seveso were lower and the follow-up shorter than those in the industrial settings (22 An increased risk of lung cancer is also present in the most informative cohort studies, again especially in the more highly exposed subcohorts. The relative risk for lung cancer in the combined highly exposed subcohorts was estimated to be 1.4 (statistically significant). It is possible that lung cancer relative risks of this order could result from confounding by smoking, but only if there is a pronounced difference in smoking habits between the exposed population and the referent populations, a difference that seems unlikely. It therefore seems unlikely that confounding by smoking can explain all the excess lung cancer risk, although it could explain part of it. It is also possible that other occupational carcinogens, many of which would affect the lung, are causing some confounding. Several other malignant neoplasms have been reported sporadically to be at increased prevalence in some populations exposed to TCDD, but none of these were consistendy increased within the individual cohorts. For example, soft-tissue sarcomas were present in the Seveso population, but only in the zone that overall had the lowest exposure (25) ; no such increase was present in the German (20, 21) 
Animal Carcinogenicty Data
In a number of experiments with rats and mice in which TCDD was administered, increases in the incidence of liver tumors were consistently found in both males and females. In addition, several other neoplasms were increased in rats, mice, and Syrian hamsters, induding thyroid follicular cell adenomas, lymphomas, and alveolar/ bronchiolar adenomas and carcinomas; but these effects were dependent on the species, sex, and route of administration of TCDD. In addition, tumors developed at a number of unusual sites such as the tongue, hard palate, and nasal turbinates in rats (26) (27) (28) (29) (30) (31) . Although they are extremely low, the doses resulting in increased tumor incidence in rodents are very close to doses that are toxic in the same species. These data led to the condusion that there is sufficient evidence in experimental animals for the carcinogenicity of TCDD. It is notable that the tissue concentrations of TCDD in one of the studies with rats given doses that produced a significant increase in tumor incidence were in the same range as those experienced in some highly exposed human populations.
Evaluation of much smaller databases (32, 33) doses of PCBs and PCDFs to produce symptoms. Fatal liver disease is now 2 to 3 times more frequent than national rates in both cohorts. In Japan there is a 3-fold excess of liver cancer mortality in men, which was already detectable and even higher at 15 years than after 22 years of follow-up. In Taiwan, after 12 years of follow-up, there is no excess of liver cancer mortality. Based on these data it was concluded that there is inadequate evidence in humans for the carcinogenicity of PCDFs.
There are no long-term carcinogenicity studies on PCDFs, but some tumor promotion studies were evaluated in which rats and mice were exposed to some of the congeners following short-duration exposure to known carcinogens (38) (39) (40) (41) Most human studies on reproductive effects of PCDDs concerned paternal exposure, usually long after high exposure had occurred; these provide limited evidence of alterations in hormone levels, sperm characteristics, and immune system. In experimental animals, however, TCDD is both a developmental and reproductive toxicant. The developing embryo/fetus appears to be more sensitive than adult animals to the adverse effects of TCDD. Perturbations of the reproductive system in adult animals require overtly toxic doses. In contrast, effects on the developing organism occur at doses more than two orders of magnitude lower than those that are toxic to the mother. Sensitive targets include the developing reproductive, nervous, and immune systems. In 10 ng TCDD/kg to mice resulted in an increase in mortality from influenza infection and is the lowest dose that produces an adverse effect yet reported for this compound (42) .
In addition to these system and organ specific effects of TCDD, exposure of animals leads to an increase in cell proliferation, hyperplasia, and neoplasia in a number of tissues, although it is difficult to define a role based on effective doses for any of these processes (which are normally measured over short-term periods) in neoplasia. Changes in cell growth homeostasis occur during tumor promotion and may be related to alterations in apoptosis, growth factor expression, and growth factor and nuclear hormone receptor levels. It would appear, however, that the primary effects of TCDD and probably other PCDDs and PCDFs are not mediated by a direct-acting genotoxic mode of action. 
Discussion
A number of questions arise from these Working Group evaluations, some of which were partially addressed during the IARC 1997 meeting (1). The following discussion of these questions has been made without reference to the Working Group members.
Is it unusual to base an epidemiologic evaluation on an aggregation of mortality due to all cancers combined? The usual situation is for mortality from one or a small number of specific tumors to be associated with an exposure. Although tobacco smoking is causally related to deaths from tumors in a number of organs, statistical significance has been repeatedly shown for the relationship with specific individual tumor types. Why should TCDD be treated differently? There are at least two proffered reasons. Few people in a small number of populations have been exposed to high levels of TCDD; hence, if it is a risk factor for several tumor types, perhaps the incidence of a particular tumor type may never be elevated to a level of significance. A parallel, if imperfect, example is environmental tobacco smoke (i.e., smoking-related tumors among nonsmokers). The average relative risk of lung cancer from passive smoking, as estimated by meta-analysis of a large number of epidemiologic studies, is about 1.2 (43) , whereas among tobacco smokers the relative risk for lung cancer can be 20 .0 or more. The U.S. Environmental Protection Agency has performed an informal meta-analysis of TCDD and related chemicals and soft-tissue sarcoma, but the more prominent cancers deserving such treatment must include lung cancer because it is the one that shows overall the highest increased risk. The other proffered reason is that TCDD is a powerful tumor promoter but does not initiate a carcinogenic process itself. In a particular studied population where TCDD is a common exposure, segments of that population may have been exposed to different initiating agents, each with a different organ specificity. Ideally, of course, these factors should have been taken into account in the study analysis for possible confounders. One specific example relevant to these evaluations is the Yusho incident in Japan (35, 36) . Although the exposure in Japan was to PCDFs, not PCDDs, it was considered that the biologic effects of both types of chemicals are mediated by the AhR; consequently, differences in the type of cancer outcome presumably would be due to differences in the initiating agent. Japan is an area of moderately high prevalence of hepatitis virus and both hepatitis B virus (HBV) and hepatitis C virus (HCV) are already recognized liver cancer risk factors (44 Is TCDD a highly potent carcinogen? The dose levels required to produce significant increases in tumor incidence in rodents are very low. As a standardized measure of potency, Gold et al. (50) calculated that the median toxic dose for TCDD-induced hepatocellular carcinomas in female rats in the Kociba et al. (29) experiment was 0.065 ligIkg body weight/day normalized to a lifespan of 2 years. This is the lowest value of any studied compound. However, the doses required for a carcinogenic effect are also very close to those doses in the same species that produce toxicity in a much shorter time; hence, the demonstrable carcinogenic dose window is narrow. Furthermore, in contrast to certain other carcinogens, the increased proportion of tumor-bearing animals is not great. It is dear from studies of other agents that carcinogenic potency may vary greatly between species (e.g., aflatoxin B1 in rats and mice) and attempts to extrapolate potency data from rodents to man must be viewed with caution.
With respect to PCDF/PCB contamination of rice oil, has there been adequate explanation of the differences in cancer incidence and mortality between Japan (where liver cancer mortality is currently 3-fold higher in the affected population) and Taiwan (where there is no increase in liver tumors)? The available time for cancer development in Japan is 22 years, compared with only 12 years in Taiwan. Thus, the current epidemiologic evidence is judged to be inadequate but in a few more years this situation may change as the follow-up period for Taiwan gets doser to the current Japanese follow-up. However, two features of the Japanese data suggest that this prediction is not inevitable. Differences in cancer mortality between the Japanese exposed and referent populations are not monotonically increasing with time. One example is mentioned in Polychlorinated Dibenzo-para-Dioxins and Polychlorinated Dibenzofurans (1) : the relative risk for liver cancer mortality in men at 15 years was 5.6 (p< 0.0 1), whereas it was 3.4 (p< 0.01) at 22 years. Another example is the relative risk for mortality from cancer of the lung, trachea, and bronchus, which at 15 years was 3.3 (p<0.01) but was 1.8 at 22 years (no longer significant) (35, 36) . However, these changes remain consistent with PCDF exposure being a risk factor. If, as is proposed, the principal action of these compounds is tumor promotion, the total cancer burden may not have changed but the emergence of certain cancers may have been accelerated. If this argument is to stand, similar evidence of early emergence of specific cancers, followed by the slower increase of these same cancers in referent populations, should be evident. We are not aware that this has occurred.
